Clinical Trial Update: Oral Prednisone Regimens to Optimize the Therapeutic Strategy in Patients With Organizing Pneumonia Post-COVID-19 [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating oral prednisone regimens to optimize therapy in patients with organizing pneumonia after COVID-19.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• COVID-19 Pneumonia
• Organizing Pneumonia

Drugs mentioned

• PREDNISONE (Prednisone)

Snippet

Sponsor: Hospital Universitari Vall d'Hebron Research Institute | Conditions: COVID-19 Pneumonia | Phase 4 | Status: UNKNOWN